#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

byTeddy Guo

April 1, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

RelatedReports

StudyGraphics

#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma

May 20, 2022

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

StudyGraphics

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

May 19, 2022

#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression

StudyGraphics

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

May 4, 2022

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

StudyGraphics

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

April 27, 2022

Shorter time to angioplasty may improve heart attack outcomes

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

Increased mortality among parents of children with major congenital anomalies

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

P2Y12 inhibitor monotherapy after coronary stenting

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

RelatedReports

#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

Increased mortality among parents of children with major congenital anomalies

P2Y12 inhibitor monotherapy after coronary stenting

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get 2MM+ Premium Access

Recent Reports

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

RELATED REPORTS

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get 2MM+ Premium Access

Recent Reports